Pneumologie 2007; 61 - V141
DOI: 10.1055/s-2007-973354

Marrow Biopsy in Granulomatous Disorders: When and Why?

M Bratkovskis 1, I Ronis 2
  • 1The State Agency of TB and Lung Diseases
  • 2The Centre of Pathology

Marrow-biopsy to a rare kind of biopsies used in diagnostics of Granulomatous Disorders.

269 biopsies were done at our Center as routine method of analysis when diffusive pathology in lungs was detected.

Methods: 57 analytical investigations were done among 269 marrow biopsies in connection with Granulomatous: 28 biopsies (or 49,1%) were positive.

Pathology

Biopsies/Posit.

%

Tuberculosis-miliary

38/19

33,3%

Sarcoidosis

17/8

14,1%

Histiocytosis X

2/1

1,7%

Total:

57/28

49,1%

We made marrow biopsies as last non-operational kind of biopsies in diagnostic algorithm of our investigations for patients with Granulomatous.

Conclusions: In our opinion, the usage of marrow biopsy in diagnostics of Granulomatous Disorders has typical evidence.

Marrow biopsies: When? 1. Tuberculosis-miliary or Sarcoidosis generalisation?

Metastases in marrow – or Granulomatous?

Unknown aneamia in granulomatous inflammation.

Sarcoidosis in marrow -indication by hormone therapy!

Why? Marrow biopsy is positive:-simple techniques biopsy and absence of complication.

negative: – rare Granulomatous Disordes localisation in marrow (˜ 5%); -marrow biopsy is not much effectual (˜50% of all biopsies).